Skip to content

A clinical trial to study the effects of Bobath therapy with and without EMG Biofeedback therapy in stroke patients

Comparative efficacy of EMG Biofeedback therapy along with Bobath therapy and Bobath therapy alone on lower extremity functions, balance and gait in patients with stroke: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051999
Enrollment
30
Registered
2023-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I699- Sequelae of unspecified cerebrovascular diseases

Interventions

Intervention1: EMG Biofeedback therapy, Bobath therapy: The intervention group will receive EMG Biofeedback therapy for 15 minutes along with Bobath therapy for 45 minutes and home exercise program.

Sponsors

SANLAP KUNDU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both male and female patients aged between 40 – 65 years. 2. Patients with first attack of stroke, diagnosed by a physician. 3. Duration of stroke 3 months to 3 years. 4. Patient has no cognitive impairment and has a MMSE Score = 24. 5. Grade of spasticity upto 2 in lower extremity on Modified Ashworth Scale. 6. Patient is in Brunnstorm lower limb recovery stage 3 and 4. 7. Patient should have passive 10° or greater ankle dorsiflexion. 8. Patient can sit independently on a plinth. 9. Patient should be ambulatory either independently or with some assistive aid.

Exclusion criteria

Exclusion criteria: 1. Patient with any sensory deficit of the lower extremity. 2. Problems with vision, like – homonymous hemianopsia, hemi agnosia, visual agnosia etc. 3. Patients with hearing loss. 4. Patients with hemineglect. 5. Patients with sensory, conduction or global aphasia. 6. Musculoskeletal conditions like – fracture, contracture and deformity in lower extremity. 7. Diagnosed neurological diseases like – Parkinsonism, Dementia, Peripheral nerve injury in the lower extremity etc. 8. Diagnosed systemic diseases like – uncontrolled hypertension etc. and/or peripheral vascular disease in lower extremity like – Raynaud’s disease etc.

Design outcomes

Primary

MeasureTime frame
1. Lower extremity function by – Lower Extremity Subscale of Fugl Meyer Assessment [FMA]. 2. Balance by –Timed Up and Go [TUG] Test. 3. Gait by – 10-meter Walk Test [10mWT].Timepoint: 2 times – on day 0 and after 4 weeks of intervention.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactSanlap Kundu

The West Bengal University of Health Sciences

drpravinkumar@gmail.com9815365870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026